Bio

Sal Guccione joined Akoya in 2018 as a Managing Director of Specialty Chemicals. He brings more than 30 years of leadership experience, including CEO, CFO and head of strategic planning/M&A in the specialty chemicals and pharmaceutical ingredients and services industries. His experience includes public and private equity-backed companies, as well as operating partner at the private equity level. He has significant company build-up experience for domestic and international businesses. Sal has been instrumental in building and managing businesses focused on personal care ingredients, nutritional ingredients, active pharmaceutical ingredients, pharmaceutical research services, biotechnology research products, surfactant chemicals and adhesives and sealants. Most recently, Sal was President and Chief Executive Officer of Aceto Corporation, a $600+ million revenue company focused on specialty chemicals, nutritional ingredients and pharmaceutical products. Prior to Aceto, Sal was Operating Partner at Arsenal Capital Partners, an industrial and healthcare focused private equity investment firm with approximately $3 billion in equity raised. Sal played an important role in Arsenal’s successful platform investment in Royal Adhesives and Sealants, originally a relatively small manufacturer and marketer of adhesives and sealant products which grew to over $600 million in revenue under Arsenal Capital. Prior to that, Sal served as Chief Executive Officer and Chief Financial Officer of WIL Research Company, a private equity-backed multinational contract research, development and manufacturing organization that served the pharmaceuticals and chemicals industries. WIL was purchased for $105 million, went through a strategic investment and growth period, and ultimately sold for $500 million, achieving a 63% IRR. Sal was also Executive Vice President, Strategy, Chief Financial Officer and Vice President, Corporate Development of Cambrex Corporation, a publicly-traded $1+ billion market value international manufacturer and marketer of active pharmaceutical ingredients and biotechnology products. Before Cambrex, Sal was Vice President and general manager of ISP Personal Care, a global developer, manufacturer and marketer of specialty chemical ingredients for the personal care industry. Sal holds a Bachelor of Science degree in chemical engineering from Lehigh University and an MBA in Finance from New York University’s Stern School of Business.